Halozyme Therapeutics EPS Basic from Accounting Change (Quarterly) Trends

Halozyme Therapeutics, Inc. (HALO)

67.31 -1.64 (-2.38%) USD | NASDAQ | Dec 30, 15:07

View EPS Basic from Accounting Change (Quarterly) for HALO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	--
Merck & Co., Inc.	--
AIM ImmunoTech, Inc.	--
Bristol Myers Squibb Co.	--
Protalix Biotherapeutics, Inc.	--